Compare TENX & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TENX | AFCG |
|---|---|---|
| Founded | 1967 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.2M | 63.8M |
| IPO Year | 2001 | 2020 |
| Metric | TENX | AFCG |
|---|---|---|
| Price | $15.99 | $2.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $29.67 | $4.50 |
| AVG Volume (30 Days) | ★ 368.7K | 273.9K |
| Earning Date | 03-10-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 7.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $24,563,601.00 |
| Revenue This Year | N/A | $1,410.52 |
| Revenue Next Year | N/A | $15.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.64 | $2.06 |
| 52 Week High | $18.38 | $5.87 |
| Indicator | TENX | AFCG |
|---|---|---|
| Relative Strength Index (RSI) | 61.35 | 63.31 |
| Support Level | $12.71 | $2.73 |
| Resistance Level | $16.27 | $3.35 |
| Average True Range (ATR) | 1.31 | 0.15 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 86.99 | 90.12 |
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.